Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.
Share or print this source review
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.
Clinical context remains essential
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
The non-label dialysis regimens are separate GlobalRPh reference material, not manufacturer instructions. No renal-adjusted meningitis regimen is inferred.
Check source scope before reading a dose
Merrem IV - UCSF Infectious Diseases Management Program
Product / population
UCSF adult IV meropenem, standard indications only.
Renal method
Intermittent HD versus CVVHD.
Source revision
Online guidance checked 2026-11-07; section revision not established.
UCSF Infectious Diseases Management Program · UCSF adult IV meropenem, standard indications only.
Renal method: Intermittent HD versus CVVHD. Source date: Online guidance checked 2026-11-07; section revision not established. Retrieved: 2026-11-07
Professional guidance with defined scope. Publication date, institutional setting and source limitations remain controlling. This is not automatic preference over another source.
For a standard infection, the institution lists 500 mg IV once, then every evening on intermittent HD. Its CVVHD standard is 1 g IV every 8 hours. Meningitis and cystic fibrosis have separate schedules. Confirm flow, indication and infusion duration before using this institutional guidance.
RDM73-merrem-iv-professional-1 · Source locator: Hemodialysis, standard dosing row
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
GlobalRPh Renal Dosing Master v7.4. Review the retrieval and revision dates attached to each source. Selecting a reference does not imply clinical verification.
